The European Medicines Agency has recommended the approval of Blue Earth Diagnostics’ prostate cancer PET imaging agent.
Ivenix reeled in the first tranche of $50 million in equity, which will support its bid for FDA clearance of its next-gen infusion pump.
Invitae boosted its genetic testing menu with a new test for the diagnosis of spinal muscular atrophy, the second-leading genetic disease in infants.
The FDA approved Medtronic’s latest iteration of its CoreValve Evolut TAVR for patients who are too frail for open-heart surgery.
Roche has teamed up with Loxo Oncology to develop a pan-tropomyosin receptor kinase immunohistochemistry test.
The FDA warned of a higher rate of cardiac events in patients receiving Abbott's Absorb stent compared to those treated with a metal stent.
MedLumics has raised $37 million to run clinical trials of its atrial fibrillation device.
Using instant wave-free ratio (iFR), a pressure-derived index, could lead to quicker, more cost-effective heart disease diagnoses and treatments.
GE Healthcare has bought wireless fetal monitoring business Monica Healthcare.
Siemens and HeartFlow have inked a deal to combine the former’s CT scanners with the latter’s noninvasive CAD test.